Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

5.99
Delayed Data
As of Aug 22
 -0.22 / -3.54%
Today’s Change
5.88
Today|||52-Week Range
27.02
-66.76%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close6.21
Today’s open6.21
Day’s range5.97 - 6.28
Volume1,633,874
Average volume (3 months)1,717,035
Market cap$377.3M
Dividend yield--
Data as of 08/22/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)-30.53%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.04+0.59%
AVDLAvadel Pharmaceutica...+0.08+0.90%
PGNXProgenics Pharmaceut...-0.01-0.17%
TLGTTeligent Inc+0.39+6.39%
Data as of 08/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)$0.12
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts